Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. 
This report contains market size and forecasts of Urokinase for Injection in global, including the following market information:
Global Urokinase for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Urokinase for Injection Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Urokinase for Injection companies in 2021 (%)
The global Urokinase for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urokinase Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Urokinase for Injection include NDPharm, Wanhua Biochem, Jiangxi Haoran Bio-Pharma and Jiangsu Aidea Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Urokinase for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urokinase for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Urokinase for Injection Market Segment Percentages, by Type, 2021 (%)
Urokinase Powder
Urokinase Solution
Global Urokinase for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Urokinase for Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Urokinase for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Urokinase for Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urokinase for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Urokinase for Injection revenues share in global market, 2021 (%)
Key companies Urokinase for Injection sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Urokinase for Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NDPharm
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical